We are live on
!
Find out more
Allianz Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
45.23%
This Fund
S&P 500
This Quarter
Est. Return
+20.6%
1 Year Est. Return
+45.23%
3 Year Est. Return
+125.62%
5 Year Est. Return
+152.86%
10 Year Est. Return
+730.76%
AUM
$123B
AUM Growth
+$27.7B
(+29%)
Cap. Flow
+$11.7B
Cap. Flow
% of AUM
9.52%
Top 10 Holdings %
Top 10 Hldgs %
25.5%
Holding
2,260
New
268
Increased
1,140
Reduced
651
Closed
117
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.76B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$2.25B |
| 3 |
NVIDIA
NVDA
|
+$1.26B |
| 4 |
Amazon
AMZN
|
+$652M |
| 5 |
Apple
AAPL
|
+$516M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VG
Venture Global Inc
VG
|
+$1B |
| 2 |
Qualcomm
QCOM
|
+$354M |
| 3 |
Johnson & Johnson
JNJ
|
+$192M |
| 4 |
Micron Technology
MU
|
+$166M |
| 5 |
Cboe Global Markets
CBOE
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.01% |
| 2 | Miscellaneous | 20.62% |
| 3 | Healthcare | 8.85% |
| 4 | Financials | 8.52% |
| 5 | Consumer Discretionary | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Vaxcyte
PCVX
$8.81B
| $459K | ﹤0.01% |
7,891
+791
| +11% | +$43K |
|
2002
National Health Investors
NHI
$3.4B
| $454K | ﹤0.01% |
5,957
-39,359
| -87% | -$3.01M |
|
2003
Infosys
INFY
$45.8B
| $454K | ﹤0.01% |
43,306
-28,110
| -39% | -$352K |
|
2004
JPMorgan BetaBuilders Japan ETF
BBJP
$19.6B
| $452K | ﹤0.01% |
+6,000
| New | +$442K |
|
2005
Vera Therapeutics
VERA
$2.43B
| $451K | ﹤0.01% |
10,500
+1,800
| +21% | +$67.1K |
|
2006
PUT
MetLife
MET
$62.4B
| $448K | ﹤0.01% |
5,300
+600
| +13% | +$48.4K |
|
2007
FNB Corp
FNB
$6.5B
| $446K | ﹤0.01% |
23,399
-12,082
| -34% | -$215K |
|
|
RAPP
2008
Rapport Therapeutics
RAPP
$2.05B
| $446K | ﹤0.01% |
10,700
-2,500
| -19% | -$91.9K |
|
2009
Summit Therapeutics
SMMT
$13.9B
| $434K | ﹤0.01% |
29,800
+7,600
| +34% | +$135K |
|
2010
PUT
Monolithic Power Systems
MPWR
$56.1B
| $415K | ﹤0.01% |
+300
| New | +$450K |
|
2011
Indivior Pharmaceuticals
INDV
$4.04B
| $409K | ﹤0.01% |
12,310
+1,010
| +9% | +$36.6K |
|
2012
Oppenheimer Holdings
OPY
$1.28B
| $408K | ﹤0.01% |
+3,869
| New | +$394K |
|
2013
Structure Therapeutics
GPCR
$2.78B
| $408K | ﹤0.01% |
7,600
-1,000
| -12% | -$44.2K |
|
2014
Planet Fitness
PLNT
$3.84B
| $396K | ﹤0.01% |
7,595
-9,603
| -56% | -$563K |
|
2015
PUT
Cencora
COR
$61.7B
| $396K | ﹤0.01% |
1,400
-4,300
| -75% | -$1.24M |
|
2016
XBP Global Holdings
XBP
$35M
| $392K | ﹤0.01% |
168,751
| – | – |
|
2017
Hanmi Financial
HAFC
$954M
| $381K | ﹤0.01% |
11,765
-73,566
| -86% | -$2.2M |
|
2018
Beam Therapeutics
BEAM
$2.4B
| $381K | ﹤0.01% |
11,100
+2,300
| +26% | +$69.4K |
|
2019
UroGen Pharma
URGN
$2.04B
| $372K | ﹤0.01% |
10,100
| – | – |
|
2020
Restaurant Brands International
QSR
$26.3B
| $371K | ﹤0.01% |
4,638
+186
| +4% | +$14.2K |
|
2021
Edgewise Therapeutics
EWTX
$4.74B
| $370K | ﹤0.01% |
+9,100
| New | +$314K |
|
|
TLN
2022
Talen Energy Corp
TLN
$13.5B
| $365K | ﹤0.01% |
951
-84
| -8% | -$30.8K |
|
2023
Excelerate Energy
EE
$1.13B
| $358K | ﹤0.01% |
+9,419
| New | +$324K |
|
2024
BridgeBio Pharma
BBIO
$13.4B
| $358K | ﹤0.01% |
4,800
-5,000
| -51% | -$350K |
|
2025
Shoals Technologies Group
SHLS
$1.19B
| $356K | ﹤0.01% |
36,000
-1,000
| -3% | -$9.08K |
|
Similar funds
Allianz Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Allianz Asset Management held 2,260 positions worth $123B, up 29% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Allianz Asset Management deployed $11.7B of net new capital in Q2 2026, opening 268 new positions and adding to 1,140 existing holdings. Its largest new stake was Rocket Lab Corp: 2,187,993 shares worth $222M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Venture Global Inc, an estimated $1B trimmed.
- Allianz Asset Management's largest Q2 2026 buy was Rocket Lab Corp: 2,187,993 shares worth $222M.
- Allianz Asset Management added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $2.76B increase.
- Allianz Asset Management's biggest Q2 2026 reduction was Venture Global Inc, cutting an estimated $1B.
- Allianz Asset Management fully exited CSG Systems International in Q2 2026, selling an estimated $39.2M.
- Allianz Asset Management's ten largest holdings make up 26% of its $123B portfolio in Q2 2026.
- Allianz Asset Management opened 268 new positions and closed 117 in Q2 2026.
- Allianz Asset Management's portfolio value rose 29% quarter-over-quarter to $123B.
Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.